To overview |
|
| | |||
| CEO |
| Dr. Ludwin Monz becomes CEO of Carl Zeiss Meditec | Downloads and Links | ||
| With effect from the end of today’s Annual General Meeting, Dr. Ludwin Monz is the new CEO of Carl Zeiss Meditec AG and as announced on 18 January follows Dr. Michael Kaschke, who resumes as Chairman of the company’s Supervisory Board | RTF Documents
english (66 KB)Further Information 
Deutsche Version
| ||
| JENA/Germany, 04.03.2010. Dr. Ludwin Monz is the new CEO of Carl Zeiss Meditec. He takes over from Dr. Michael Kaschke. At today’s Annual General Meeting, Kaschke was elected back to the Supervisory Board and was appointed its Chairman in the subsequent Supervisory Board meeting. “I am looking forward to the new task and will continue the path the company has taken towards sustainable growth”, explains Dr. Ludwin Monz, CEO of Carl Zeiss Meditec AG, continuing: “Customer-oriented innovation, excellent service and expansion into new markets as part of our corporate RACE programme are clearly the three most important strategic initiatives for the coming months.” Dr. Ludwin Monz has been a member of Carl Zeiss Meditec AG’s Management Board since October 2007 and is responsible for the largest strategic business unit, Ophthalmological Systems. Prior to this he headed up the Microsurgery strategic business unit for over six years. During this time he developed this department into a growing and highly profitable part of the company. Numerous innovative products were launched on the market under his leadership. With a doctorate in physics and an MBA, Monz joined the Carl Zeiss Group in 1994 and has worked in medical technology since 2000. In addition to various R&D positions, Dr. Ludwin Monz has worked in numerous key roles within the Group. “Having Dr. Ludwin Monz as our new CEO has allowed us to win a successor known for innovation and growth from our own ranks. With ten years of expertise in medical technology he knows the company, its customers and their needs and Carl Zeiss Meditec’s energy and potential. I know that Carl Zeiss Meditec is in excellent hands with its current Management Board team and look forward to supporting the company again in the future as Supervisory Board Chairman”, says Dr. Michael Kaschke, Supervisory Board Chairman of Carl Zeiss Meditec AG. Eva Sesselmann Director Corporate Communications Carl Zeiss Meditec AG Phone: +49 3641 220-331 Fax: +49 3641 220-112 E-Mail: 
press@meditec.zeiss.comPatrick Kofler Director Investor Relations Carl Zeiss Meditec AG Phone: +49 3641 220-106 Fax: +49 3641 220-117 E-Mail:
investors@meditec.zeiss.comNumber: 0048-2010-ENG OP Number of Words: 359 Number of Characters: 2250 |
|
